Pemetrexed Plus Cisplatin Neoadjuvant Therapy Followed By Surgery and Radiation in Mesothelioma

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
8537
Conditions: Mesothelioma
Start Date: June 1, 2005
Phase: Phase II
Status: Completed
NCT ID: NCT00192010
Study Type: Interventional
Intervention: Drug: pemetrexed|Drug: cisplatin
Study Design: Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Results: No Results Available
Sponsors: Eli Lilly and Company
Ages: Adult|Senior
Enrollment: 54
Funded By: Industry
First Received: September 12, 2005
End Date: February 1, 2010
Last Updated: August 5, 2010
Last Verified: August 1, 2010